Adial Pharmaceuticals Total Liabilities (Quarterly) Analysis

Adial Pharmaceuticals Inc (ADIL)

1.01 0.00 (0.00%) USD | NASDAQ | Nov 04, 16:00

1.08 +0.07 (+6.93%) After-Hours: 04:31

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
June 30, 2024	0.6719M
March 31, 2024	0.5627M
December 31, 2023	0.6531M
September 30, 2023	0.5282M
June 30, 2023	0.4618M
March 31, 2023	2.462M
December 31, 2022	2.456M
September 30, 2022	2.333M
June 30, 2022	2.962M
March 31, 2022	3.256M
December 31, 2021	3.967M
September 30, 2021	3.246M
June 30, 2021	3.234M
March 31, 2021	3.008M
December 31, 2020	1.505M

Date	Value
September 30, 2020	1.093M
June 30, 2020	0.6819M
March 31, 2020	0.3898M
December 31, 2019	0.5391M
September 30, 2019	0.7769M
June 30, 2019	0.6266M
March 31, 2019	0.3292M
December 31, 2018	0.258M
September 30, 2018	0.3228M
June 30, 2018	1.481M
March 31, 2018	1.388M
December 31, 2017	1.032M
September 30, 2017	0.743M
June 30, 2017	0.6612M
December 31, 2016	0.255M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

0.3898M

Minimum

Mar 2020

3.967M

Maximum

Dec 2021

1.79M

Average

1.505M

Median

Dec 2020

Total Liabilities (Quarterly) Benchmarks

NovaBay Pharmaceuticals Inc	4.542M
Palatin Technologies Inc	10.85M
iBio Inc	7.41M
Theriva Biologics Inc	14.74M
Oragenics Inc	1.383M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly)	4.949M
Shareholders Equity (Quarterly)	4.277M